| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |